{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:03:05Z","timestamp":1772114585392,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1993,11,1]],"date-time":"1993-11-01T00:00:00Z","timestamp":752112000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1993,11]]},"DOI":"10.1007\/bf01715050","type":"journal-article","created":{"date-parts":[[2005,6,12]],"date-time":"2005-06-12T19:01:34Z","timestamp":1118602894000},"page":"217-222","source":"Crossref","is-referenced-by-count":35,"title":["Lymphoid subsets in acute myeloid leukemias: Increased number of cells with NK phenotype and normal T-cell distribution"],"prefix":"10.1007","volume":"67","author":[{"given":"M. B.","family":"Vidriales","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Orfao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. C.","family":"L\u00f3pez- Berges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ciudad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Moro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. F.","family":"San Miguel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01715050_CR1","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1182\/blood.V74.5.1690.1690","volume":"74","author":"A Adler","year":"1989","unstructured":"Adler A, Albo V, Blatt J, Whiteside TL, Herberman RB (1989) Interleukin-2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients. II. Feasibility of LAK generation in children with active disease and in remission. Blood 74:1690\u20131697","journal-title":"Blood"},{"key":"BF01715050_CR2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1182\/blood.V71.3.709.709","volume":"71","author":"A Adler","year":"1988","unstructured":"Adler A, Chervenick PA, Whiteside TL, Lotzov\u00e1 E, Herberman RB (1988) Interleukin-2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients. I. Feasibility of LAK generation in adult patients with active disease and in remission. Blood 71:709\u2013716","journal-title":"Blood"},{"key":"BF01715050_CR3","first-page":"1509","volume":"46","author":"A Adler","year":"1987","unstructured":"Adler A, Chervenick P, Whiteside T, Lotzov\u00e1 E, Herberman RB (1987) IL-2 mediated in vitro stimulation of killer cells derived from peripheral blood (PB)\/bone marrow (BM) of acute leukemia patients. Fed Proc 46:1509 (abstr 6957)","journal-title":"Fed Proc"},{"key":"BF01715050_CR4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/1097-0142(19900801)66:3<469::AID-CNCR2820660312>3.0.CO;2-E","volume":"66","author":"ZA Afify","year":"1990","unstructured":"Afify ZA, Abdel-Mageed A, Findley HW, Ragab AH (1990) Cytotoxicity of purified Leu 19+ cells from the peripheral blood of children with acute lymphocytic leukemia. Cancer 66:469\u2013473","journal-title":"Cancer"},{"key":"BF01715050_CR5","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1365-2141.1991.tb08579.x","volume":"77","author":"E Archimbaud","year":"1991","unstructured":"Archimbaud E, Bailly M, Dor\u00e9 JF (1991) Inducibility of lymphokine-activated killer (LAK) cells in patients with acute myelogenous leukaemia in complete remission and its clinical relevance. Br J Haematol 77:328\u2013334","journal-title":"Br J Haematol"},{"key":"BF01715050_CR6","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1182\/blood.V77.10.2237.2237","volume":"77","author":"B Autran","year":"1991","unstructured":"Autran B, Leblond V, Sadat-Sowti B, Lefranc E, Got P, Sutton L, Binet JL, Debre P (1991) A soluble factor release by CD8+CD57+lymphocytes from bone marrow transplanted patients inhibits cell-mediated cytolysis. Blood 77:2237\u20132241","journal-title":"Blood"},{"key":"BF01715050_CR7","volume-title":"(Biomedical-Data Package): Statistical software","author":"WJ Dixon","year":"1983","unstructured":"Dixon WJ (1983) (Biomedical-Data Package): Statistical software. University of California, Berkeley"},{"key":"BF01715050_CR8","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1182\/blood.V78.4.1041.1041","volume":"78","author":"R Foa","year":"1991","unstructured":"Foa R, Fierro MT, Cesano A, Guarini A, Bonferroni M, Raspadori D, Miniero R, Lauria F, Gavosto F (1991) Defective lymphokine-activated cell generation and activity in acute leukemia patients with active disease. Blood 78:1041\u20131046","journal-title":"Blood"},{"key":"BF01715050_CR9","first-page":"964","volume":"51","author":"R Foa","year":"1991","unstructured":"Foa R, Guarini A, Gillio-Tos A, Cardona S, Fierro MT, Meloni G, Tosti S, Mandelli F, Gavosto F (1991) Peripheral blood and bone marrow immunophenotypic and functional modifications induced in acute leukemia patients treated with interleukin-2: evidence of in vitro lymphokine-activated killer cell generation. Cancer Res 51:964\u2013968","journal-title":"Cancer Res"},{"key":"BF01715050_CR10","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ijc.2910420412","volume":"42","author":"C Gambacorti-Passerini","year":"1988","unstructured":"Gambacorti-Passerini C, Rivoltini L, Supino R, Mariani M, Parmiani G (1988) Differential lysis of melanoma clones by autologous recombinant interleukin-2 activated lymphocytes. Relationship with spontaneous resistance to doxorubicin (Dx). Int J Cancer 42:544\u2013548","journal-title":"Int J Cancer"},{"key":"BF01715050_CR11","first-page":"174","volume-title":"Manual of clinical and laboratory immunology. Section D: Immune cell phenotyping by flow cytometry","author":"JV Giorgi","year":"1992","unstructured":"Giorgi JV, Kesson AM, Chou CC (1992) Immunodeficiency and infectious diseases. In: Rose NR, de Macario EC, Fahey JL, Freidman H, Penn GM (eds) Manual of clinical and laboratory immunology. Section D: Immune cell phenotyping by flow cytometry. Amer Soc Microbiol, Washington DC, pp 174\u2013181"},{"key":"BF01715050_CR12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ajh.2830390203","volume":"39","author":"M Gonz\u00e1lez","year":"1992","unstructured":"Gonz\u00e1lez M, San Miguel JF, Gasc\u00f3n A, Moro MJ, Hern\u00e1ndez JM, Ortega F, Jim\u00e9nez R, Guerras L, Romero M, Casanova F, Sanz MA, Portero JA, Orfao A (1992) Increased expression of natural killer-associated and activation antigens in multiple myeloma. Am J Hematol 39:84\u201389","journal-title":"Am J Hematol"},{"key":"BF01715050_CR13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0167-5699(86)90076-9","volume":"7","author":"LL Lanier","year":"1987","unstructured":"Lanier LL, Phillips JH (1987) Evidence for three types of human cytotoxic lymphocyte. Immunol Today 7:132\u2013135","journal-title":"Immunol Today"},{"key":"BF01715050_CR14","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.4049\/jimmunol.137.9.2735","volume":"137","author":"LL Lanier","year":"1986","unstructured":"Lanier LL, Phillips JH, Hackett J, Tutt M, Kuman V (1986) Natural killer cells: definition of a cell type rather than a function. J Immunol 137:2735\u20132739","journal-title":"J Immunol"},{"key":"BF01715050_CR15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0145-2126(91)90129-H","volume":"15","author":"SH Lim","year":"1991","unstructured":"Lim SH, Worman CP, Jewell A, Goldstone AH (1991) Production of tumor-derived suppressor factor in patients with acute myeloid leukemia. Leuk Res 15:263\u2013268","journal-title":"Leuk Res"},{"key":"BF01715050_CR16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ajh.2830370206","volume":"37","author":"E Lotzov\u00e1","year":"1991","unstructured":"Lotzov\u00e1 E, Savary CA, Schachnr JR, Huh JO, McCredie K (1991) Generation of cytotoxic NK cells in peripheral blood and bone marrow of patients with acute myelogenous leukemia after continuous infusion with recombinant interleukin-2. Am J Hematol 37:88\u201399","journal-title":"Am J Hematol"},{"key":"BF01715050_CR17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0145-2126(91)90127-F","volume":"15","author":"E Lotzov\u00e1","year":"1991","unstructured":"Lotzov\u00e1 E, Savary CA, Totpal K, Schachner J, Lichtiger B, McCredie KB, Freireich EJ (1991) Highly oncolytic adherent lymphocytes: therapeutic relevance for leukemia. Leuk Res 15:245\u2013254","journal-title":"Leuk Res"},{"key":"BF01715050_CR18","first-page":"207","volume-title":"Experimental hematology today","author":"E Lotzov\u00e1","year":"1989","unstructured":"Lotzov\u00e1 E, McCredie KB, Muesse L, Dicke KA, Freireich EJ (1989) Natural killer cells in man: their possible involvement in leukemia and bone marrow transplantation. In: Baum SJ, Ledney (eds) Experimental hematology today. Springer, Berlin Heidelberg New York, p 207"},{"key":"BF01715050_CR19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0090-1229(92)90001-5","volume":"63","author":"LG Lum","year":"1992","unstructured":"Lum LG, Ueda M (1992) Immunodeficiency and the role of suppressor cells after the bone marrow transplantation. Clin Immunol Immunopathol 63:103\u2013109","journal-title":"Clin Immunol Immunopathol"},{"key":"BF01715050_CR20","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1182\/blood.V78.9.2182.2182","volume":"78","author":"D Maraninchi","year":"1991","unstructured":"Maraninchi D, Blaise D, Viens P, Brandely M, Olive D, L\u00f3pez M, Sainty D, Marit G, Stoppa AM, Reiffers J et al. (1991) High-dose recombinant interleukin-2 and acute myeloid leukemias in relapse. Blood 78:2182\u20132187","journal-title":"Blood"},{"key":"BF01715050_CR21","first-page":"105","volume":"41","author":"D Milosevic","year":"1991","unstructured":"Milosevic D, Marinkovic M, Suvajdzic N, Spuzic I (1991) Determination of T lymphocyte subpopulations in malignant lymphoproliferative diseases. Glas Srp Akad Nauka [Med] 41:105\u2013111","journal-title":"Glas Srp Akad Nauka [Med]"},{"key":"BF01715050_CR22","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.4049\/jimmunol.143.10.3183","volume":"143","author":"A Nagler","year":"1989","unstructured":"Nagler A, Lainer LL, Cwirla S, Phillips JH (1989) Comparative studies of human FcR III-positive and -negative natural killer cells. J Immunol 143:3183\u20133191","journal-title":"J Immunol"},{"key":"BF01715050_CR23","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.4049\/jimmunol.148.8.2429","volume":"148","author":"B Naume","year":"1992","unstructured":"Naume B, Gately M, Espevik T (1992) A comparative study of IL-12 (cytotoxic lymphocyte maturation factor), IL-2 and IL-7-induced effects on immunomagnetically purified CD56+ NK cells. J Immunol 148:2429\u20132436","journal-title":"J Immunol"},{"key":"BF01715050_CR24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1600-0609.1991.tb00134.x","volume":"47","author":"AK Palucka","year":"1991","unstructured":"Palucka AK, Porwit A, Reizenstein P (1991) Resistance of leukemic blasts to lymphokine-activated killer (LAK)-mediated cytotoxicity is not related to their adhesion properties. Eur J Haematol 47:123\u2013127","journal-title":"Eur J Haematol"},{"key":"BF01715050_CR25","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/bjc.1988.221","volume":"58","author":"G Pizzolo","year":"1988","unstructured":"Pizzolo G, Trentin L, Vinante F, Agostini C, Zambello R, Masciarelli M, Feruglio C, Dazzi F, Todeschini G, Chilosi M, et al. (1988) Natural killer cell function and lymphoid sub-populations in acute non-lymphoblastic leukemia in complete remission. Br J Cancer 58:368\u2013372","journal-title":"Br J Cancer"},{"key":"BF01715050_CR26","first-page":"93","volume":"2","author":"SB Pollack","year":"1983","unstructured":"Pollack SB (1983) In vivo functions of natural killer cells. Surv Synth Pathol Res 2:93\u201398","journal-title":"Surv Synth Pathol Res"},{"key":"BF01715050_CR27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0268-960X(90)90049-X","volume":"4","author":"RC Rees","year":"1990","unstructured":"Rees RC (1990) MHC restricted and non-restricted killer lymphocytes. Blood Rev 4:204\u2013210","journal-title":"Blood Rev"},{"key":"BF01715050_CR28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/10428199209049794","volume":"7","author":"SJ Richards","year":"1992","unstructured":"Richards SJ, Scott CS (1992) Human NK cells in health and disease: clinical, functional, phenotypic and DNA genotypic characteristics. Leukemia Lymphoma 7:377\u2013399","journal-title":"Leukemia Lymphoma"},{"key":"BF01715050_CR29","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1182\/blood.V76.12.2421.2421","volume":"76","author":"MJ Robertson","year":"1990","unstructured":"Robertson MJ, Ritz J (1990) Biology and clinical relevance of human natural killer cells. Blood 76:2421\u20132438","journal-title":"Blood"},{"key":"BF01715050_CR30","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJM198704093161501","volume":"316","author":"SA Rosenberg","year":"1987","unstructured":"Rosenberg SA, Lotze MT, Mull LM, Chang AE, Avis FP, Leitman S, Linehan WM, Robertson GN, Lee RE, Rubin JT, Seipp CA, Simpson CG, White DE (1987) A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 316:889\u2013897","journal-title":"N Engl J Med"},{"key":"BF01715050_CR31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ajh.2830200308","volume":"20","author":"JF San Miguel","year":"1985","unstructured":"San Miguel JF, Caballero MD, Gonz\u00e1lez M (1985) T-cell sub-populations in patients with monoclonal gammopathies: essential monoclonal gammopathy, multiple myeloma and Waldestr\u00f6m's macroglobulinemia. Am J Haematol 20:267\u2013273","journal-title":"Am J Haematol"},{"key":"BF01715050_CR32","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1182\/blood.V78.3.768.768","volume":"78","author":"JF San Miguel","year":"1991","unstructured":"San Miguel JF, Hern\u00e1ndez JM, Gonz\u00e1lez-Sarmiento R, Gonzalez M, S\u00e1nchez I, Orfao A, Ca\u00f1izo MC, L\u00e1pez-Borrasca A (1991) Acute leukemia after primary myelodisplastic syndrome: immunophenotyping, genotypic and clinical characteristics. Blood 78:768\u2013774","journal-title":"Blood"},{"key":"BF01715050_CR33","first-page":"108","volume":"3","author":"JF San Miguel","year":"1989","unstructured":"San Miguel JF, Ojeda E, Gonz\u00e1lez M, Orfao A, Ca\u00f1izo MC, S\u00e1nchez I, L\u00f3pez-Borrassca A (1989) Prognostic value of immunological markers in acute myeloblastic leukemia. Leukemia 3:108\u2013111","journal-title":"Leukemia"},{"key":"BF01715050_CR34","first-page":"183","volume":"17","author":"CA Savary","year":"1989","unstructured":"Savary CA, Lotzov\u00e1 E (1989) Natural killer cell-mediated inhibition of growth myeloid and lymphoid clonogenic leukemias. Exp Hematol 17:183\u2013187","journal-title":"Exp Hematol"},{"key":"BF01715050_CR35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-3083.1988.tb02410.x","volume":"28","author":"D Sorskaar","year":"1988","unstructured":"Sorskaar D, Forre O, Tjonneland S, Lie SO (1988) Altered natural killer cell activity in childhood acute non-lymphoid leukaemia. Augmented natural killer activity and cells expressing the Leu 7 and Leu 11b (CD16) markers in the bone marrow of children in remission. Scand J Immunol 28:11\u201317","journal-title":"Scand J Immunol"},{"key":"BF01715050_CR36","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/978-1-4684-5535-9_68","volume":"237","author":"JA Tratkiewicz","year":"1988","unstructured":"Tratkiewicz JA, Szer J, Boyd RL (1988) Are lymphokine-activated killer cells a possible form of leukemia immunotherapy? Adv Exp Med Biol 237:447\u2013450","journal-title":"Adv Exp Med Biol"},{"key":"BF01715050_CR37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2249.1990.tb05241.x","volume":"80","author":"JA Tratkiewicz","year":"1990","unstructured":"Tratkiewicz JA, Szer J (1990) Loss of natural killer activity as an indicator of relapse in acute leukemia. Clin Exp Immunol 80:241\u2013246","journal-title":"Clin Exp Immunol"},{"key":"BF01715050_CR38","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2249.1990.tb06447.x","volume":"80","author":"JA Tratkiewicz","year":"1990","unstructured":"Tratkiewicz JA, Szer J, Boyd RL (1990) Lymphokine activated killer cytotoxicity against leukaemic blast cells. Clin Exp Immunol 80:94\u201399","journal-title":"Clin Exp Immunol"},{"key":"BF01715050_CR39","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/1097-0142(19890801)64:3<667::AID-CNCR2820640317>3.0.CO;2-5","volume":"64","author":"L Trentin","year":"1989","unstructured":"Trentin L, Pizzolo G, Ferugio C, Zambello R, Masciarelli M, Bulian P, Agostini C, Vinante F, Zanotti R, Semenzato G (1989) Functional analysis of cytotoxic cells in patients with acute nonlymphoblastic leukemia in complete remission. Cancer 64:667\u2013672","journal-title":"Cancer"},{"key":"BF01715050_CR40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1200\/JCO.1992.10.1.33","volume":"10","author":"JS Weber","year":"1992","unstructured":"Weber JS, Yang JC, Topalian SL, Schwartzentruber DJ, White DE, Rosenberg SA (1992) The use of interleukin-2 and lymphokine-activated killer cells for the treatment of patients with non-Hodgkin's lymphoma. J Clin Oncol 10:33\u201340","journal-title":"J Clin Oncol"},{"key":"BF01715050_CR41","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0145-2126(91)90462-3","volume":"15","author":"S Yamada","year":"1991","unstructured":"Yamada S, Komiyama A (1991) Decrease in number of CD16 (Leu 11)+CD45RA(2h4)+cells and defective production of natural killer cytotoxic factor in childhood acute lymphoblastic leukemia. Leuk Res 15:785\u2013790","journal-title":"Leuk Res"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01715050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01715050\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01715050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T18:05:09Z","timestamp":1706292309000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01715050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,11]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1993,11]]}},"alternative-id":["BF01715050"],"URL":"https:\/\/doi.org\/10.1007\/bf01715050","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,11]]}}}